Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice
- 1 January 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 5 (4), 463-466
- https://doi.org/10.1093/carcin/5.4.463
Abstract
Long-term oral administration of the adrenal steroid, dehydroepiandrosterone (DHEA), has previously been shown to inhibit the development of spontaneous breast cancer and chemically induced lung and colon tumors in various mouse strains. In the two-stage skin papilloma system in the mouse, topical application of DHEA inhibits both 7,12-dimethylbenz[a]anthracene initiation and 12-O-tetradecanoylphorbol-13-acetate promotion of these tumors. The synthetic steroid, 3β-methylandrost-5-en-17-one, which, unlike DHEA, is not demonstrably estrogenic in the rat, also inhibits papilloma development.This publication has 3 references indexed in Scilit:
- Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate.Proceedings of the National Academy of Sciences, 1983
- Effect of Food Restriction, Dehydroepiandrosterone, or Obesity on the Binding of 3h-7,12-dimethylbenz(a)anthracene to Mouse Skin DnaJournal of Gerontology, 1983
- Initiation of Precocious Sexual Maturation in the Immature Rat Treated with Dehydroepiandrosterone1Endocrinology, 1975